Sampre Nutritions Announces Stock Split, Bonus Issue, and Capital Expansion

1 min read     Updated on 19 Sept 2025, 03:03 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
whatsapptwittershare
Overview

Sampre Nutritions Limited (BSE: 530617) has approved several strategic moves to enhance shareholder value and improve stock liquidity. The company plans a 2:1 stock split, reducing share face value from INR 10 to INR 5. A 1:1 bonus issue will double shareholders' holdings. The authorized share capital will increase from INR 35 crores to INR 100 crores, subject to shareholder approval. The bonus shares will be issued from the securities premium account. The stock split is expected to complete in 2-3 months, with bonus shares credited by November 19, 2025. These actions aim to attract more retail investors and potentially increase trading volumes.

19819996

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited, a company listed on the Bombay Stock Exchange (BSE: 530617), has unveiled a series of strategic moves aimed at enhancing shareholder value and improving stock liquidity. The company's Board of Directors has approved several key proposals that are set to reshape its capital structure.

Stock Split to Enhance Liquidity

In a bid to make its shares more accessible to retail investors, Sampre Nutritions has approved a stock split that will reduce the face value of its equity shares from INR 10.00 to INR 5.00 per share. This 2:1 split is expected to double the number of outstanding shares, potentially increasing market liquidity.

Bonus Issue to Reward Shareholders

Alongside the stock split, the company has announced a generous 1:1 bonus issue. Shareholders will receive one bonus equity share for every existing share held, effectively doubling their shareholding without any additional cost.

Authorized Capital Increase

To accommodate these changes and future growth plans, Sampre Nutritions will seek shareholder approval to increase its authorized share capital from INR 35.00 crores to INR 100.00 crores. This significant expansion provides the company with ample headroom for potential future capital raises or corporate actions.

Financial Implications

The bonus shares will be issued from the company's securities premium account, which had a balance of INR 59.87 crores as of March 31, 2025. The issuance will require INR 21.56 crores from this account, leaving a substantial buffer for future use.

Implementation Timeline

Action Expected Completion
Stock Split 2-3 months
Bonus Share Credit By November 19, 2025

Shareholder Approval and Next Steps

All these proposals are subject to shareholder approval through a postal ballot. The company has already approved the draft notice for the postal ballot, which will be sent to shareholders in due course.

Market Impact

These corporate actions are likely to be viewed positively by the market, as they typically signal management's confidence in the company's future prospects. The stock split and bonus issue, in particular, may attract more retail investors by making the shares more affordable and potentially increasing trading volumes.

Sampre Nutritions' Managing Director, Brahma Gurbani, signed off on these significant changes, which were approved in a board meeting lasting from 1:30 PM to 2:30 PM IST on September 19, 2025.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%+10.40%+54.42%+315.30%+32.86%+838.76%
Sampre Nutritions
View in Depthredirect
like19
dislike

Sampre Nutritions Limited to Consider Stock Split and Bonus Share Issuance

1 min read     Updated on 15 Sept 2025, 08:59 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
whatsapptwittershare
Overview

Sampre Nutritions Limited has announced a board meeting on September 19, 2025, to consider two major corporate actions: a potential stock split and the issuance of bonus shares. The stock split would involve sub-dividing equity shares, while bonus shares would be additional shares issued to existing shareholders at no cost. These actions, if approved, could enhance stock liquidity and benefit shareholders. The meeting notice was filed with BSE Limited in compliance with regulatory requirements.

19495784

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited has announced a crucial board meeting scheduled for September 19, 2025, to deliberate on two significant corporate actions that could potentially benefit its shareholders.

Key Agenda Items

Stock Split Consideration

The board will evaluate the possibility of a sub-division or split of the company's equity shares under Section 61(1)(d) of the Companies Act, 2013. A stock split would increase the number of outstanding shares while proportionately reducing the price per share, potentially making the stock more accessible to a broader range of investors.

Bonus Share Issuance

Directors will consider proposing the issuance of bonus equity shares to existing eligible members of the company. Bonus shares are additional shares given to current shareholders without any cost, effectively increasing their shareholding without diluting the value of their investment.

Meeting Details

The meeting notice, signed by Managing Director Brahma Gurbani on September 15, 2025, was filed with the BSE Limited as per the regulatory requirements. The company adhered to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in providing this intimation.

Company Background

Sampre Nutritions Limited, with its registered office and manufacturing units located in Medchal, Telangana, operates in the food processing sector. The company has been in operation since its incorporation in 1991.

Implications for Investors

While the outcomes of the board meeting are yet to be determined, both potential actions—stock split and bonus share issuance—are generally viewed favorably by the market. These corporate actions, if approved, could enhance liquidity in the stock and reward existing shareholders.

Investors and market participants will be keenly awaiting the decisions from this upcoming board meeting, as they could significantly impact the company's share structure and valuation in the near term.

Note: Investors are advised to wait for the official announcement post the board meeting for confirmed details on these corporate actions.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%+10.40%+54.42%+315.30%+32.86%+838.76%
Sampre Nutritions
View in Depthredirect
like19
dislike
More News on Sampre Nutritions
Explore Other Articles
105.61
+2.07
(+2.00%)